July 13, 2021 • 3:00 PM - 4:00 PM ET


Learn about a recently announced precision medicine initiative to equip health care providers with the power of proteomic technology to inform decisions at the point of care. With the goal of demonstrating the impact that proteomic tests can have on improving outcomes, lowering total cost of care, and increasing patient engagement and involvement in their care, clinical trials will be launched with several health system partners. During this webinar, UC Health’s Medical Director and CU Innovations’ Director of Business Development and SomaLogic’s Executive Vice President for Healthcare Markets will discuss using proteomics in clinical practice and how partnerships can improve health through innovation.

  • Understand SomaLogic’s new clinical tests and hear about the latest innovation in diagnostic testing using proteomics
  • Hear what UC Health thinks are the measurable clinical benefits and keys to successful adoption for new technologies, like the proteomic-based tests introduced by SomaLogic
  • Learn about CU Innovations’ unique approach to partnerships that bring innovations to emerging clinical practice areas like cardio oncology

Webinar Speakers

Angela  Bakker Lee
Angela Bakker Lee, PhD
Executive Vice President, Healthcare Markets
SomaLogic
Mike McGarry
Mike McGarry
Director, Business Development
CU Innovations
Clay Smith
Clay Smith, MD
Director, Blood Disorders and Cell Therapies Center
UCHealth
Medical Director
UCHealth/CU Innovations


Contact



General Inquiries:

World Congress Customer Relations
Phone: 781-939-2400
Toll-free: 800-767-9499
Email: wcreg@worldcongress.com

Receive Email Updates

Be the first to learn about our upcoming events, promotions and news.